Blood-testing startup accused of not resolving issues found during inspection earlier this year that created instant jeopardy to patient health and safety’Troubled blood-testing startup Theranos could be banned from practicing for two years for failing to resolve major problems at its main laboratory in California,federal health regulators have warned.
The Centers for Medicare and Medicaid Services (CMS), which monitors clinical lab standards among other things, or wrote to Theranos management on 18 March notifying the company that it had 10 days to reply or would have its license revoked and its owners banned from running any lab.
Continue reading...
Source: theguardian.com